S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7229 −0.32%
CLOSED · 15:40 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

ADXN

Addex Therapeutics Ltd.
NASDAQ
3.65
−0.06 −1.62%
USD · close Sep 4

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose ADXN in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
Timothy Mark Dyer9.0%
SCHEDULE 13D/A · filed Sep 4 · activist · EDGAR ↗

“The Reporting Person acquired the securities of the Issuer at founding, through the exercise of options, acquisitions through participation in private placements and in consideration for his services as Chief Executive Officer of the Issuer. The reporting person also received shares issuable upon ex…”

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch ADXN. Know when insiders buy.
One email the day a filing lands. Free.